EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Accuracy of LI-RADS Version 2018 for Hepatocellular Carcinoma against Histopathology: A Retrospective Cohort

Firas Abdullah AlBaghdadi

University of Thi-Qar Journal Of Medicine · 04.06.2026 · 30 (1) · 11-18

DOI: 10.32792/jmed.2026.30.44 ↗

Kurz gefasst

Fachartikel in der Zeitschrift University of Thi-Qar Journal Of Medicine, online erschienen am 04.06.2026. Verfasst von Firas Abdullah AlBaghdadi. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Liver Imaging Reporting and Data System (LI-RADS) standardizes interpretation and reporting of liver computed tomography (CT) and magnetic resonance imaging (MRI) in patients at risk for hepatocellular carcinoma (HCC). Its per-category diagnostic performance against a histopathological reference standard has been characterized largely in high-resource settings.

Objective

To determine the diagnostic accuracy of LI-RADS version 2018 (v2018) for HCC against histopathology in at-risk patients, to quantify per-category positive predictive value (PPV), and to compare the LR-5, combined LR-4/5, and ordinal LI-RADS strategies. Patients and methods. A retrospective single-center diagnostic-accuracy cohort study was conducted at Al-Hussein Teaching Hospital. At-risk patients with a multiphasic liver CT or MRI and a histopathological reference standard (resection, explant, or core-needle biopsy) for the index observation were included. The primary outcomes were per-category PPV for HCC, and the sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of LR-5, combined LR-4/5, and ordinal LI-RADS.

Results

Of 388 patients screened, 247 observations in 218 patients formed the analytic cohort; 158 (64.0%) were HCC. PPV for HCC rose monotonically across categories: 0% (LR-1), 4.5% (LR-2), 9.1% (LR-3), 44.4% (LR-4), and 92.6% (LR-5). LR-5 achieved a sensitivity of 82.3% (95% confidence interval [CI] 75.4–87.9%) and specificity of 94.4% (95% CI 87.4–98.2%), with an AUC of 0.88 (95% CI 0.83–0.93).

Conclusions

LI-RADS v2018 LR-5 demonstrated high specificity and good sensitivity for HCC against histopathology in this Iraqi cohort.

Zitieren

APA

AlBaghdadi, F. A. (2026). Diagnostic Accuracy of LI-RADS Version 2018 for Hepatocellular Carcinoma against Histopathology: A Retrospective Cohort. University of Thi-Qar Journal Of Medicine, 30(1), 11-18. https://doi.org/10.32792/jmed.2026.30.44

Vancouver

AlBaghdadi FA. Diagnostic Accuracy of LI-RADS Version 2018 for Hepatocellular Carcinoma against Histopathology: A Retrospective Cohort. University of Thi-Qar Journal Of Medicine. 2026;30(1):11-18. doi:10.32792/jmed.2026.30.44

BibTeX
@article{AlBaghdadi2026,
  author = {AlBaghdadi, Firas Abdullah},
  title = {Diagnostic Accuracy of LI-RADS Version 2018 for Hepatocellular Carcinoma against Histopathology: A Retrospective Cohort},
  journal = {University of Thi-Qar Journal Of Medicine},
  year = {2026},
  volume = {30},
  number = {1},
  pages = {11--18},
  doi = {10.32792/jmed.2026.30.44}
}
Kostenlos starten →